Literature DB >> 16802325

A population-based study of colorectal cancer histology in the United States, 1998-2001.

Sherri L Stewart1, Jennifer M Wike, Ikuko Kato, Denise R Lewis, Frances Michaud.   

Abstract

BACKGROUND: Histology is an important factor in the etiology, treatment, and prognosis of cancer. The purpose of this study was to descriptively characterize colorectal cancer (CRC) histology in the United States population.
METHODS: Data from cancer registries in the National Program of Cancer Registries (NPCR) or Surveillance, Epidemiology and End Results (SEER) program, representing 88% of the U.S. population, were used in the study. The analysis included 522,630 microscopically confirmed CRC cases diagnosed from 1998-2001.
RESULTS: About 96% of CRCs were adenocarcinomas, approximately 2% were other specified carcinomas (including carcinoid tumors), about 0.4% were epidermoid carcinomas, and about 0.08% were sarcomas. The proportion of epidermoid carcinomas, mucin-producing carcinomas, and carcinoid tumors was greater among females. Several histologic patterns with regard to race and ethnicity existed, including a higher percentage of carcinoid tumors among most non-white populations. With respect to age, higher percentages of sarcomas, mucin-producing adenocarcinomas, signet ring cell tumors, and carcinoid tumors were found in individuals under age 40. Overall, adenocarcinomas were more likely to be diagnosed at regional stages with moderate differentiation. Compared with other adenocarcinomas, signet ring cell tumors were more often poorly differentiated and were at distant stage at diagnosis. Carcinoid tumors and sarcomas were mainly poorly differentiated and were at localized stage at diagnosis. Small cell carcinomas were more likely undifferentiated and were at distant stage at diagnosis.
CONCLUSIONS: To date, this is the largest population-based study to analyze CRC histology in the United States. Distinct demographic and clinical patterns associated with different histologies may be helpful for future epidemiologic, laboratory, and clinical studies.

Entities:  

Mesh:

Year:  2006        PMID: 16802325     DOI: 10.1002/cncr.22010

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  38 in total

1.  Opportunistic intestinal infections and risk of colorectal cancer among people with AIDS.

Authors:  Fatma M Shebl; Eric A Engels; James J Goedert
Journal:  AIDS Res Hum Retroviruses       Date:  2012-02-02       Impact factor: 2.205

2.  Clinical characteristics, risk factors and outcomes of asymptomatic rectal neuroendocrine tumors.

Authors:  Sun-Hye Ko; Myong Ki Baeg; Seung Yeon Ko; Hee Sun Jung
Journal:  Surg Endosc       Date:  2017-01-11       Impact factor: 4.584

3.  A 3E8.scFv.Cys-IR800 Conjugate Targeting TAG-72 in an Orthotopic Colorectal Cancer Model.

Authors:  Li Gong; Haiming Ding; Nicholas E Long; Brandon J Sullivan; Edward W Martin; Thomas J Magliery; Michael F Tweedle
Journal:  Mol Imaging Biol       Date:  2018-02       Impact factor: 3.488

4.  Oncogenic Role of BOLL in Colorectal Cancer.

Authors:  Ki Joo Kang; Jeung Hui Pyo; Kyung Ju Ryu; Sung Jin Kim; Jung Min Ha; Kyu Choi; Sung Noh Hong; Byung-Hoon Min; Dong Kyung Chang; Hee Jung Son; Poong-Lyul Rhee; Jae J Kim; Young-Ho Kim
Journal:  Dig Dis Sci       Date:  2015-01-21       Impact factor: 3.199

5.  Patients with Non-Hodgkin's Lymphoma Are at Risk of Adenomatous Colon Polyps.

Authors:  Hamzah Abu-Sbeih; Ellie Chen; Osman Ahmed; Niharika Mallepally; Phillip Lum; Wei Qiao; Hun Ju Lee; Robert Bresalier; Lan Sun Wang; Brian Weston; Gottumukkala S Raju; Yinghong Wang
Journal:  Dig Dis Sci       Date:  2019-05-03       Impact factor: 3.199

6.  Colorectal cancer: prognostic values.

Authors:  Suzana Manxhuka-Kerliu; Skender Telaku; Halil Ahmetaj; Arijeta Baruti; Sadushe Loxha; Agron Kerliu
Journal:  Bosn J Basic Med Sci       Date:  2009-02       Impact factor: 3.363

7.  Changes on the disease pattern of primary colorectal cancers in Southern China: a retrospective study of 20 years.

Authors:  Shenghong Zhang; Yi Cui; Zijin Weng; Xiaorong Gong; Minhu Chen; Bihui Zhong
Journal:  Int J Colorectal Dis       Date:  2009-05-08       Impact factor: 2.571

8.  Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polyps.

Authors:  Joanne Ngeow; Brandie Heald; Lisa A Rybicki; Mohammed S Orloff; Jin Lian Chen; Xiuli Liu; Lisa Yerian; Joseph Willis; Heli J Lehtonen; Rainer Lehtonen; Jessica L Mester; Jessica Moline; Carol A Burke; James Church; Lauri A Aaltonen; Charis Eng
Journal:  Gastroenterology       Date:  2013-02-08       Impact factor: 22.682

Review 9.  Current concepts in colorectal cancer prevention.

Authors:  Patricia A Thompson; Eugene W Gerner
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2009-08       Impact factor: 3.869

Review 10.  Dendritic cell vaccine therapy for colorectal cancer.

Authors:  Amanda L Wooster; Lydia H Girgis; Hayley Brazeale; Trevor S Anderson; Laurence M Wood; Devin B Lowe
Journal:  Pharmacol Res       Date:  2020-12-28       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.